Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A ordinary share, par value $0.0001
-
Shares outstanding
-
17,264,276
-
Total 13F shares
-
1,509,117
-
Share change
-
-881,766
-
Total reported value
-
$15,804,316
-
Price per share
-
$10.40
-
Number of holders
-
7
-
Value change
-
-$9,094,416
-
Number of buys
-
1
-
Number of sells
-
3
Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) as of Q3 2025
As of 30 Sep 2025,
Translational Development Acquisition Corp. - Class A ordinary share, par value $0.0001 (TDACU) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,509,117 shares.
The largest 7 holders included
Alberta Investment Management Corp, Calamos Advisors LLC, D. E. Shaw & Co., Inc., RIVERNORTH CAPITAL MANAGEMENT, LLC, Yakira Capital Management, Inc., FLOW TRADERS U.S. LLC, and UBS Group AG.
This page lists
7
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.